CHARLOTTE BYRD: Open Payments
NPI 1285225987 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,492 in 76 payments from 27 companies in 2025. Trend: 2023 $752 · 2024 $980 · 2025 $1,492
Food & beverage: $1,409Education: $83
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 9 | $189 |
| Janssen Biotech, Inc. | 11 | $166 |
| Daiichi Sankyo Inc. | 7 | $158 |
| Eisai Inc. | 5 | $95 |
| Novartis Pharmaceuticals Corporation | 5 | $95 |
| SEAGEN INC. | 1 | $83 |
| Merck Sharp & Dohme LLC | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| PFIZER INC. | 3 | $52 |
Products named: ERLEADA, MONJUVI, Lenvima, Enhertu, Fabhalta, KEYTRUDA, JAKAFI, RYBREVANT.
Industry payments across AL — which companies pay providers there.
